Wasif Khan

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. doi request reprint B-lymphocyte tolerance and effector function in immunity and autoimmunity
    Wasif N Khan
    Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA
    Immunol Res 57:335-53. 2013
  2. doi request reprint B cell receptor and BAFF receptor signaling regulation of B cell homeostasis
    Wasif N Khan
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Immunol 183:3561-7. 2009

Detail Information

Publications2

  1. doi request reprint B-lymphocyte tolerance and effector function in immunity and autoimmunity
    Wasif N Khan
    Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL, 33136, USA
    Immunol Res 57:335-53. 2013
    ..Here, we discuss how gene expression and signaling networks regulate peripheral B-cell tolerance, B-cell effector functions and emerging therapies targeting B-cell signaling in autoimmune diseases. ..
  2. doi request reprint B cell receptor and BAFF receptor signaling regulation of B cell homeostasis
    Wasif N Khan
    Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA
    J Immunol 183:3561-7. 2009
    ....

Research Grants10

  1. Stage-specific Signaling in Peripheral B Cell Selection
    Wasif Khan; Fiscal Year: 2006
    ..This new knowledge can lead to the development of novel therapeutics for the treatment of B cell-mediated autoimmune diseases and immunodeficiencies and B cell lymphomas. ..
  2. Transcription Regulation by B-Cell Receptor Signaling
    Wasif Khan; Fiscal Year: 2004
    ..Identification of these important missing links may reveal new immunotherapeutic targets for intervention in B-cell deficiency diseases such as XLA. ..
  3. Stage-specific Signaling in Peripheral B Cell Selection
    Wasif N Khan; Fiscal Year: 2010
    ..This new knowledge can lead to the development of novel therapeutics for the treatment of B cell-mediated autoimmune diseases and immunodeficiencies and B cell lymphomas. ..